669.00
Idexx Laboratories Inc stock is traded at $669.00, with a volume of 495.63K.
It is down -3.03% in the last 24 hours and up +5.29% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$689.93
Open:
$689.93
24h Volume:
495.63K
Relative Volume:
1.09
Market Cap:
$21.31B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
53.03
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
-5.72%
1M Performance:
+5.29%
6M Performance:
+29.13%
1Y Performance:
+58.94%
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IDXX
Idexx Laboratories Inc
|
669.00 | 55.09B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
567.16 | 217.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
A
Agilent Technologies Inc
|
144.52 | 41.62B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
DHR
Danaher Corp
|
220.44 | 156.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
MTD
Mettler Toledo International Inc
|
1,388.96 | 28.66B | 3.87B | 829.75M | 847.84M | 39.48 |
|
WAT
Waters Corp
|
377.98 | 22.59B | 2.91B | 622.64M | 620.14M | 10.48 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveMarket Weekly Review & Reliable Volume Spike Trade Alerts - newser.com
What machine learning models say about IDEXX Laboratories Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
Is IDEXX Laboratories Inc. stock supported by strong cash flows - newser.com
Does IDEXX Laboratories Inc. fit your quant trading modelMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Is IDEXX Laboratories Inc. (IX1) stock prepared for digital transitionTrade Performance Summary & Weekly Watchlist of Top Performers - newser.com
Will IDEXX Laboratories Inc. stock recover after recent dropEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Trend analysis for IDEXX Laboratories Inc. this weekJuly 2025 Recap & Growth Focused Stock Reports - newser.com
IDEXX Laboratories Amends Credit Agreement for Flexibility - TipRanks
Building trade automation scripts for IDEXX Laboratories Inc.2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Idexx Laboratories Shares Reach New Highs Amid Insider Selling Activity - AD HOC NEWS
Insider Move: Nimrata Hunt Exercises Options, Realizing $4.10M At IDEXX Laboratories - Benzinga
Idexx Laboratories Insider Sold Shares Worth $6,629,014, According to a Recent SEC Filing - MarketScreener
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$6.63 Million in Common Stock - 富途牛牛
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $775 - 富途牛牛
Here’s Why IDEXX Laboratories (IDXX) Surged in Q3 - Insider Monkey
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $775 From $700 - MarketScreener
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):